Mr. Chair, again, just as a clarification, the reason the label change power was included in the act for therapeutic products in the first place was to make sure we didn't have to intervene by seizing a product or removing its licence. Actually, that's often not in the best interest of patients or consumers because, again, they don't get the product, and at that point it's just over a labelling issue.
Having a label change power that's really geared.... It's very important that the threshold is that you do it to prevent an injury and only then. It's really making sure that you can instruct that through an order, to have it become a safe labelling, again.
In terms of the regulations, they don't have the power to instruct a change in label. There are rules about complying with the label expectations, but if there's something dangerous on the label, then, basically, the idea of the order would be to mandate that change without disrupting supply. It gives the company a chance to relabel and to make sure that you're not taking the product away from Canadians. That's really the idea of a label change power. Again, it's reserved only for those times when there's a potential injury that we have to intervene in.